U.S. flag

An official website of the United States government

NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Dec 5, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000129091.7

Allele description [Variation Report for NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg)]

NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg)

Gene:
CDH1:cadherin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q22.1
Genomic location:
Preferred name:
NM_004360.5(CDH1):c.2396C>G (p.Pro799Arg)
Other names:
NM_004360.4(CDH1):c.2396C>G
HGVS:
  • NC_000016.10:g.68829754C>G
  • NG_008021.1:g.97463C>G
  • NM_001317184.2:c.2213C>G
  • NM_001317185.2:c.848C>G
  • NM_001317186.2:c.431C>G
  • NM_004360.5:c.2396C>GMANE SELECT
  • NP_001304113.1:p.Pro738Arg
  • NP_001304114.1:p.Pro283Arg
  • NP_001304115.1:p.Pro144Arg
  • NP_004351.1:p.Pro799Arg
  • LRG_301t1:c.2396C>G
  • LRG_301:g.97463C>G
  • NC_000016.9:g.68863657C>G
  • NM_004360.3:c.2396C>G
  • NM_004360.4:c.2396C>G
  • p.P799R
Protein change:
P144R
Links:
dbSNP: rs587781335
NCBI 1000 Genomes Browser:
rs587781335
Molecular consequence:
  • NM_001317184.2:c.2213C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317185.2:c.848C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001317186.2:c.431C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004360.5:c.2396C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000183801Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 5, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients.

Keller G, Vogelsang H, Becker I, Plaschke S, Ott K, Suriano G, Mateus AR, Seruca R, Biedermann K, Huntsman D, Döring C, Holinski-Feder E, Neutzling A, Siewert JR, Höfler H.

J Med Genet. 2004 Jun;41(6):e89. No abstract available.

PubMed [citation]
PMID:
15173255
PMCID:
PMC1735803

E-cadherin mutations and cell motility: a genotype-phenotype correlation.

Mateus AR, Simões-Correia J, Figueiredo J, Heindl S, Alves CC, Suriano G, Luber B, Seruca R.

Exp Cell Res. 2009 May 1;315(8):1393-402. doi: 10.1016/j.yexcr.2009.02.020. Epub 2009 Mar 4.

PubMed [citation]
PMID:
19268661
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV000183801.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The p.P799R variant (also known as c.2396C>G) is located in coding exon 15 of the CDH1 gene. This alteration results from a C to G substitution at nucleotide position 2396. The proline at codon 799 is replaced by arginine, an amino acid with dissimilar properties. In one study, p.P799R was identified in 1 of 35 familial gastric cancer patients in a 41-year-old patient with a mixed adenocarcinoma of the gastroesophageal junction and a family history of two maternal second degree relatives with gastric cancer, but it was not found in 50 controls. Functional studies aimed to investigate the impact of this missense change on CDH1 protein function are conflicting (Keller G et al. J Med Genet. 2004 Jun;41(6):e89; Mateus AR et al. Hum Mol Genet. 2007 Jul 1;16(13):1639-47; Mateus AR et al. Exp Cell Res. 2009 May 1;315(8):1393-402; Figueiredo J et al. Eur. J. Hum. Genet., 2013 Mar;21:301-9). Additional studies investigating the impact of this missense change on the localization and abundance of CDH1 have suggested that this alteration results in a reduction of the CDH1 protein at the cell membrane (Figueiredo J et al. Eur. J. Hum. Genet., 2013 Mar;21:301-9, Sanches JM et al. Eur. J. Hum. Genet., 2015 Aug;23:1072-9). Structural analysis of P799R exhibited higher length and angle distortions and abnormal cytoskeletal organization, suggesting the formation of very dynamic and plastic cellular interactions (Mestre T et al. Sci Rep, 2016 05;6:25101). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is conflicting at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024